Back

Diabetes and the timing of complete revascularization in STEMI with multivessel disease: insights from the OPTION–STEMI trial

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: ST-elevation myocardial infarction: artificial intelligence, myocardial infarction, and complete revascularisation ST-Elevation Myocardial Infarction (STEMI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Yongwhan Lim

Chonnam National University Hospital, Gwangju (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Multi-centre study of an artificial intelligence ECG model for the detection of occlusive myocardial infarction within the UK
Doctor A. Yazdi (London, GB)
Abstract Slides
Presentation thumbnail
Artificial intelligence–enhanced detection of acute coronary occlusion in tachycardic patients using surface ECG
Doctor J. Terporten (Cologne, DE)
Abstract Slides
Presentation thumbnail
Angiographically derived radial wall strain predicts revascularization of mild-to-intermediate lesions in non-culprit vessels among patients with acute myocardial infarction
Mr D. Lu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Optimal timing of complete revascularization in patients presenting with STEMI and multivessel disease: a systematic review and meta-analysis
Doctor M. Mousa (Giza, EG)
Abstract Slides
Presentation thumbnail
Acute coronary occlusion in chest pain patients with broad QRS complex - artificial intelligence-enhanced ECG Interpretation compared to conventional electrocardiographic criteria
Doctor S. Macherey-Meyer (Cologne, DE)
Abstract Slides

Access the full session

Session thumbnail
ST-elevation myocardial infarction: artificial intelligence, myocardial infarction, and complete revascularisation

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of staged PCI of non-culprit lesions after ST-elevation MI in diabetic patients
29 June 2021
thumbnail
Congress Presentation
Effect of oral semaglutide on CV outcomes across the vascular disease spectrum, from no vascular disease to polyvascular disease, in high-risk type 2 diabetes
1 September 2025
thumbnail
Congress Presentation
The presence of adverse atherosclerotic coronary plaque features is associated with diabetes
9 May 2021
thumbnail
Congress Session
Ask the Trialists - OPTION-STEMI
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources